NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Aarti Drugs Limited (NSE: AARTIDRUGS)

AARTIDRUGS Technical Analysis
As on 23rd May 2022 AARTIDRUGS Share Price closed @ 425.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 563.81 & Strong Sell for SHORT-TERM with Stoploss of 456.51 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 427.80 Change Price %
High 428.30 1 Day 5.05 1.20
Low 418.55 1 Week 6.25 1.49
Close 425.35 1 Month -65.95 -13.42
Volume 52711 1 Year -323.95 -43.23
52 Week High 778.50 | 52 Week Low 402.45
NSE INDIA Most Active Stocks
IDEA 9.05 -0.55%
YESBANK 13.75 -1.43%
SAIL 73.95 -10.90%
BHEL 51.10 -3.77%
ASHOKLEY 135.80 4.18%
PNB 30.60 2.17%
ZOMATO 57.05 -1.72%
JINDALSTEL 395.55 -17.39%
NMDC 128.15 -12.50%
NSE INDIA Top Gainers Stocks
STERTOOLS 174.35 17.41%
SEQUENT 131.25 14.43%
BROOKS 92.10 12.45%
CAREERP 120.05 10.90%
VRLLOG 638.70 10.62%
KRISHANA 359.25 10.54%
COMPUSOFT 24.20 10.00%
APCOTEXIND 641.05 9.99%
ALPA 76.65 9.97%
ALPA 76.65 9.97%
NSE INDIA Top Losers Stocks
GPIL 310.00 -20.00%
SARDAEN 832.55 -20.00%
SHREYANIND 104.50 -18.55%
JSL 125.65 -18.09%
JINDALSTEL 395.55 -17.39%
JSLHISAR 246.10 -15.65%
JSWSTEEL 547.55 -13.24%
TATASTEEL 1022.95 -12.61%
NMDC 128.15 -12.50%
SALZERELEC 171.25 -11.52%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
AARTIDRUGS Important Levels Intraday
AARTIDRUGS Target for Month May
4th UP TARGET656.6
3rd UP TARGET593.93
2nd UP TARGET555.2
1st UP TARGET516.46
1st DOWN TARGET405.94
2nd DOWN TARGET367.2
3rd DOWN TARGET328.47
4th DOWN TARGET265.8
AARTIDRUGS Weekly Target
4th UP TARGET461.92
3rd UP TARGET448.57
2nd UP TARGET440.32
1st UP TARGET432.07
1st DOWN TARGET408.53
2nd DOWN TARGET400.28
3rd DOWN TARGET392.03
4th DOWN TARGET378.68
AARTIDRUGS Target for Year 2022
4th UP TARGET1234.38
3rd UP TARGET1013.26
2nd UP TARGET876.58
1st UP TARGET739.9
1st DOWN TARGET349.9
2nd DOWN TARGET213.22
3rd DOWN TARGET76.54
4th DOWN TARGET-144.58
AARTIDRUGS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 57.27 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 591.43
10 Day Avg Volume Traded -36.18 % Less then 10 Day Average Volume
AARTIDRUGS Other Details
Segment EQ
Market Capital 57860685824.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
Your Comments and Response on Aarti Drugs Limited
AARTIDRUGS Business Profile
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide, sodium salt, benzyl nicotinate, bisphenol ? C, bisphenol ? C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Additionally, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India. Address: Mahendra Industrial Estate, Mumbai, India, 400 022
2005-2021 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service